reviewExperimental Hematology and OncologyJan 29, 2024GOLD OA

Cancer metabolism and carcinogenesis

Emory University · Georgia Institute of Technology · +1 more institution

PubMed
Indexed incrossrefdoajpubmed

Abstract

Metabolic reprogramming is an emerging hallmark of cancer cells, enabling them to meet increased nutrient and energy demands while withstanding the challenging microenvironment. Cancer cells can switch their metabolic pathways, allowing them to adapt to different microenvironments and therapeutic interventions. This refers to metabolic heterogeneity, in which different cell populations use different metabolic pathways to sustain their survival and proliferation and impact their response to conventional cancer therapies. Thus, targeting cancer metabolic heterogeneity represents an innovative therapeutic avenue with the potential to overcome treatment resistance and improve therapeutic outcomes. This review…

No related works found for this paper.

Funding